Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 5, 2014

Biological variation of vascular endothelial growth factor

  • Sabrina Meo , Ruggero Dittadi and Massimo Gion

Corresponding author: Sabrina Meo, ABO Association c/o Regional Centre for the Study of Biological Markers of Malignancy, Ospedale Civile, 30122, ASL 12 Veneziana, Venice, Italy Phone: +39-041-5295600, Fax: +39-041-5294653,

References

1 Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4–25. 10.1210/edrv.18.1.0287Search in Google Scholar PubMed

2 Dittadi R, Meo S, Fabris F, Gasparini G, Contri D, Medici M, et al. Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different compartments. Int J Biol Markers 2001; 16: 87–96. 10.1177/172460080101600202Search in Google Scholar

3 Salven P, Orpana A, Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 1999; 5: 487–91. Search in Google Scholar

4 Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27: 409–37. 10.3109/10408368909106595Search in Google Scholar PubMed

5 Fraser CG. General strategies to set quality specifications for reliability performances characteristics. Scand J Clin Lab Invest 1999; 59: 487–90. 10.1080/00365519950185210Search in Google Scholar PubMed

Published Online: 2014-6-5
Published in Print: 2005-3-1

©2005 by Walter de Gruyter Berlin New York

Downloaded on 10.6.2024 from https://www.degruyter.com/document/doi/10.1515/CCLM.2005.059/html
Scroll to top button